BSE Live
Jan 21, 16:01Prev. Close
22.50
Open Price
22.00
Bid Price (Qty.)
22.00 (74)
Offer Price (Qty.)
22.50 (49)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Beryl Drugs (in Rs. Cr.) | Mar 18 | Mar 17 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 1.96 | 0.00 | |
| Diluted EPS (Rs.) | 1.96 | 0.00 | |
| Cash EPS (Rs.) | 0.00 | 0.00 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 0.00 | 0.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | 0.00 | 0.00 | |
| PBIT/Share (Rs.) | 0.00 | 0.00 | |
| PBT/Share (Rs.) | 0.00 | 0.00 | |
| Net Profit/Share (Rs.) | 0.00 | 0.00 | |
| NP After MI And SOA / Share (Rs.) | 0.00 | 0.00 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 10.56 | 1.89 | |
| PBIT Margin (%) | 8.50 | -1.38 | |
| PBT Margin (%) | 7.67 | -3.12 | |
| Net Profit Margin (%) | 6.21 | -3.59 | |
| NP After MI And SOA Margin (%) | 6.21 | -3.59 | |
| Return on Networth/Equity (%) | 0.00 | 0.00 | |
| Return on Capital Employed (%) | 0.00 | 0.00 | |
| Return on Assets (%) | 0.00 | 0.00 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 0.00 | 0.00 | |
| Quick Ratio (X) | 0.00 | 0.00 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 10.28 | -0.79 | |
| Interest Coverage Ratios (Post Tax) (%) | 10.28 | -0.79 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y